Caidera

Caidera is an AI-powered marketing compliance platform purpose-built for life sciences companies — including pharma, medtech, and biotech. Founded by consultants who spent years advising leading organizations such as Bayer, Takeda, B. Braun, and BioNTech, Caidera was created to solve the single biggest bottleneck in life sciences marketing: the compliance approval process. The platform reduces MLR review cycles from three to five weeks down to as little as four minutes, enabling marketing teams to create, check, and approve compliant content end-to-end in one unified environment.

Caidera serves marketing and compliance teams at regulated life sciences organizations who need to move faster without sacrificing regulatory standards. By automating the first-pass compliance review and embedding it directly into the content creation workflow, Caidera empowers content creators with clear, actionable guidance while significantly reducing the burden on compliance and MLR teams. Customers including Bayer, Bauerfeind AG, Uebe Medical, and Cepheid Deutschland have reported dramatic reductions in campaign creation time and approval costs.

Core Platform Modules

• Compliance Engine: AI-powered compliance review built specifically for life sciences. Performs live compliance checks on new and existing content, covering both local and global regulations. Delivers source-referenced findings rather than generic flags, supports a full MLR workflow with a complete audit trail, and catches regulatory issues in minutes rather than weeks.
• Content Studio: Brand-aligned content creation designed for regulated industries. Provides on-brand templates for every marketing channel, persona-aware AI content generation, multi-language support at launch speed, and a workflow built for compliance from the very first draft.

Key Capabilities

• Automated first-pass compliance review delivered in minutes, directly inside the content editor
• Live detection of issues such as unsubstantiated claims, missing fair balance, off-label indications, absent disclaimers, and brand voice inconsistencies
• Consistent application of local and global regulatory requirements across all content assets
• Clear, actionable fix suggestions provided to content creators at the point of writing
• Full MLR approval workflow with role-based access control and a complete, regulator-ready audit trail
• Persona-aware AI generation enabling rapid creation of target-group-specific campaigns
• Multi-channel publishing support, including LinkedIn, Instagram, Facebook, and email
• Ability to repurpose and schedule content across channels from a single platform

Integrations and Workflow Connectivity

• Native integrations with Veeva Vault, SharePoint, Google Drive, and Salesforce
• Connects existing content sources to the Caidera compliance engine and then publishes to all major marketing channels
• Designed to slot into existing content workflows rather than replace them, eliminating silos and centralizing compliance and creation in one place

Measured Business Impact

• Average compliance review time reduced to approximately 4 minutes per asset, compared to an industry standard of 3–5 weeks
• Approval cost per asset reduced by up to 90% compared to the industry baseline (previously estimated at approximately $25,000 per asset)
• 70% fewer post-review revisions due to compliance issues being caught upfront
• Bauerfeind AG reported 97% time saved on campaign concept development and 80% time saved on content asset creation
• Teams at Bayer, Uebe Medical, and Cepheid Deutschland report campaigns that previously took weeks now completed in hours

Trust, Security, and Compliance Standards

• GDPR compliant and EU AI Act ready
• EU data residency enforced by default — all data stored on EU servers
• Hosted on Microsoft Azure Cloud enterprise-grade infrastructure
• No training on customer data; full data sovereignty maintained at the infrastructure level
• Every change logged with role-based access control and a full audit trail suitable for regulatory submission
• Purpose-built for the compliance requirements of pharma, medtech, and biotech organizations

Team, Advisors, and Background

• Co-founded by Daniel Fernau, specializing in data science and generative AI with experience advising DAX 40 companies, and Max Sieg, a marketing strategy consultant with deep life sciences expertise
• Both founders previously worked at Campana & Schott, advising organizations including Bayer, Takeda, B. Braun, BioNTech, and Charité
• Advisory board includes Dr. Eric Schott (founder of Campana & Schott, 30+ years in management consulting), Prof. Dr. Andreas Eggert (Professor of Business and Service Marketing at Freie Universität Berlin), Dr. Dr. Matthias Gröschel (Clinician Scientist at Charité with expertise in molecular biology, epidemiology, and AI in life sciences), and Richard Gerstenberg (Board Member at Weleda AG and life sciences strategy advisor)
• Backed by leading institutions, accelerators, and government programs across Germany and the EU
• Works with dedicated implementation partners who specialize in life sciences marketing to support customer onboarding and ROI realization

Caidera's mission is to free life sciences companies from lengthy compliance approval cycles so that great marketing reaches patients and healthcare professionals faster — without cutting corners on regulatory standards.